Evidence map›Paper›PMID 35410407›Full record

ArticleCell death discovery2022

NAMPT-dependent NAD

Takuto Nishida, Isao Naguro, Hidenori Ichijo

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Period3 modulates the NADJournal of advanced research · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. The Role of NADPharmaceuticals (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Takuto NishidaLaboratory of Cell Signaling, Graduate School of Pharmaceutical Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4751-4354
Isao NaguroLaboratory of Cell Signaling, Graduate School of Pharmaceutical Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan. nagurois@mol.f.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-0338-8026
Hidenori IchijoLaboratory of Cell Signaling, Graduate School of Pharmaceutical Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan. ichijo@mol.f.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-5005-6438
The University of Tokyo · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP20gm5010001MEXT | Japan Science and Technology Agency (JST) JPMJMS2002-18MEXT | Japan Society for the Promotion of Science (JSPS) JP17H06419MEXT | Japan Society for the Promotion of Science (JSPS) JP18H02569MEXT | Japan Society for the Promotion of Science (JSPS) JP18H03995MEXT | Japan Society for the Promotion of Science (JSPS) JP18K19469MEXT | Japan Society for the Promotion of Science (JSPS) JP19J13520
6 · The paper itself

Abstract

Oxidative stress is a state in which the accumulation of reactive oxygen species exceeds the capacity of cellular antioxidant systems. Both apoptosis and necrosis are observed under oxidative stress, and we have reported that these two forms of cell death are induced in H

Identifiers

PMID35410407
PMCPMC9001718
OpenAlexW4223452433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.